ETL Newswire

More on the Health desk

• Health Oct 14, 2026 Pennsylvania Records Sixth Measles Death as Outbreak Tops 1,100 Cases A 39-year-old unvaccinated woman in Franklin County died of a probable cardiac event linked to measles complications, as the state's outbreak remains the worst in the U.S. since 1991.
  By Karen Bishop, Correspondent
• Health Oct 12, 2026 FDA Clears Immunotherapy Add-On for Stage III Colon Cancer With Specific DNA Repair Flaw The FDA approved atezolizumab plus standard chemotherapy for stage III dMMR colon cancer after a phase 3 trial showed a 50% cut in recurrence or death risk.
  By Karen Bishop, Correspondent
• Health Oct 11, 2026 US Measles Cases Top 4,000 as Pennsylvania Leads Nation in Deaths and Hospitalizations The CDC confirmed 4,080 measles cases as of October 8, a 78% jump over all of 2025, with five deaths reported in Pennsylvania and 414 hospitalizations nationwide.
  By Karen Bishop, Correspondent
• Health Oct 10, 2026 Maryland Requires Mammogram Reports to Flag Heart Risk Finding A first-of-its-kind state law that took effect Oct. 1 requires mammography centers to notify patients when scans show breast arterial calcification, a marker linked to elevated cardiovascular risk.
  By Karen Bishop, Correspondent
• Health Oct 9, 2026 Patient Navigators Boost Postpartum Care for Low-Income Mothers, Trial Finds A Northwestern Medicine randomized trial published in JAMA Health Forum found that trained lay navigators significantly improved postpartum visit rates, depression screening, and long-term primary care engagement among low-income patients.
  By Karen Bishop, Correspondent
• Health Oct 8, 2026 Pennsylvania Measles Outbreak Tops 1,000 Cases, the State's Worst in 35 Years Five people are dead and 198 have been hospitalized as the outbreak, centered in Lancaster County, spreads across 39 counties, with more than 99% of cases in unvaccinated people.
  By Karen Bishop, Correspondent
• Health Oct 6, 2026 Refugees and Legal Immigrants Lose Medicaid Coverage as Budget Law Takes Effect Provisions of the One Big Beautiful Bill Act stripped Medicaid eligibility from refugees, asylees, trafficking survivors, and Afghan allies starting October 1, leaving hundreds of thousands without affordable coverage options.
  By Karen Bishop, Correspondent
• Health Oct 3, 2026 Pennsylvania Reports Fifth Measles Death as U.S. Case Count Hits 35-Year High An unvaccinated Lancaster County resident died from measles as Pennsylvania's outbreak approaches 1,000 cases and the national total surpasses 3,600, the highest in three decades.
  By Karen Bishop, Correspondent
• Health Sep 27, 2026 FDA Clears Four Alzheimer's Blood Tests as Simpler Diagnosis Enters Primary Care Two new FDA clearances in August bring the total to four approved blood-based Alzheimer's tests, including one for symptomatic adults as young as 40, raising questions about how primary care clinicians will put results into context.
  By Karen Bishop, Correspondent
• Health Sep 24, 2026 Massachusetts Insurers Cut GLP-1 Coverage, Pushing 112,000 Off Drugs Tied to Heart Protection A state health commission report finds a 52% drop in insured GLP-1 use for obesity after carriers restricted coverage, just as research confirms stopping the drugs accelerates cardiovascular risk.
  By Karen Bishop, Correspondent
• Health Sep 22, 2026 Bangladesh Measles Death Toll Tops 1,000 Children After Vaccination Drive Falls Short A vaccine supply collapse rooted in political turmoil left roughly four million children unprotected, and an emergency campaign launched in April hasn't been enough to stop the spread.
  By Karen Bishop, Correspondent
• Health Sep 21, 2026 CAR T-Cell Therapy Sends Treatment-Resistant Rheumatoid Arthritis Into Remission in Phase 1 Trial A small Berlin trial published in Nature Medicine found that three of six patients with severe, drug-refractory rheumatoid arthritis reached medication-free remission after a single CAR T-cell infusion.
  By Karen Bishop, Correspondent
• Health Sep 20, 2026 GLP-1 Drugs Improve Diabetes Outcomes but Show No Measurable Gains in Mental Health or Employment, Study Finds A University of Chicago working paper used a decade of nationally representative survey data to test whether Ozempic and similar drugs change how patients feel, work, or relate, and found little evidence that they do.
  By Karen Bishop, Correspondent
• Health Sep 18, 2026 AI-Powered Blood Test Detects Early Pancreatic Cancer in Study of 1,800 Patients The liquid biopsy PANXEON correctly identified stage 1 and 2 pancreatic cancers 87% of the time, but researchers say larger validation studies are still needed before it reaches clinical use.
  By Karen Bishop, Correspondent
• Health Sep 17, 2026 Cervical Cancer Screening Rates Drop Sharply Among Young U.S. Women, JAMA Study Finds Nearly one in three women ages 21 to 29 had never been screened as of 2023, up from about one in eight in 2005, with the steepest gaps among uninsured women and those in Southern states.
  By Karen Bishop, Correspondent
• Health Sep 16, 2026 Endocrine Society Tells Clinicians to Measure Obesity Treatment Beyond the Scale A new scientific statement published in Endocrine Reviews argues that weight loss alone is the wrong yardstick for GLP-1 era obesity care, and calls out six research gaps that need to close before personalized treatment is possible.
  By Karen Bishop, Correspondent
• Health Sep 13, 2026 FDA Clears Four Updated COVID Vaccines for Fall 2026, but Federal Guidance on Who Should Get One Hasn't Arrived Shots targeting the XFG variant are shipping to pharmacies now, while a key federal advisory panel remains without a quorum, leaving eligibility decisions to clinicians and patients.
  By Karen Bishop, Correspondent
• Health Sep 10, 2026 Congress Subpoenas Oracle Chiefs Over VA Health Records Cost That Nearly Tripled The House Veterans Affairs Committee voted 19-0 to compel Larry Ellison and CEO Mike Sicilia to testify after the VA's electronic health record contract ballooned from $10 billion to $27 billion with most facilities still undeployed.
  By Karen Bishop, Correspondent
• Health Sep 8, 2026 Cancer Therapy Puts Treatment-Resistant Rheumatoid Arthritis Into Remission in First Clinical Trial A phase 1 trial at a Berlin hospital found that three of six patients with severe, drug-resistant rheumatoid arthritis reached sustained medication-free remission after a single CAR T-cell infusion.
  By Karen Bishop, Correspondent
• Health Sep 6, 2026 FDA Clears First RAS-Targeting Pill for Metastatic Pancreatic Cancer Daraxonrasib nearly doubled median survival over chemotherapy in a 500-patient trial, but its $39,800-a-month price tag raises immediate access questions.
  By Karen Bishop, Correspondent
• Health Sep 4, 2026 FDA Clears First mRNA Flu Vaccine for Adults 50 and Older Moderna's mFLUSIVA won full approval for the 50-to-64 age group and accelerated approval for adults 65 and up, with a confirmatory trial still required for the older cohort.
  By Karen Bishop, Correspondent
• Health Sep 2, 2026 Long-Term Melatonin Use Tied to 90% Higher Heart Failure Risk in Insomnia Patients A large multinational cohort study of more than 130,000 adults with chronic insomnia found a sharp jump in heart failure diagnoses, hospitalizations, and deaths among those who took melatonin for a year or more, though researchers caution the findings don't prove cause and effect.
  By Karen Bishop, Correspondent
• Health Aug 31, 2026 FDA Clears First RAS-Targeting Pill for Advanced Pancreatic Cancer Daraxonrasib, sold as Rasonque, nearly doubled median survival compared with standard chemotherapy in a 500-patient trial, but its $39,800 monthly list price raises immediate access questions.
  By Karen Bishop, Correspondent
• Health Aug 30, 2026 Experimental Blood Test Catches 81% of High-Risk Colorectal Polyps in International Trial The DENEB assay detected precancerous adenomas at rates no existing blood-based test has matched, but researchers say colonoscopy remains essential to confirm any positive result.
  By Karen Bishop, Correspondent
• Health Aug 29, 2026 Trump Orders MMR Vaccine Split as U.S. Measles Cases Top 2,465 An executive order signed August 10 calls for separating the combined measles, mumps, and rubella shot into three individual vaccines, drawing sharp rebukes from pediatricians and infectious disease specialists.
  By Karen Bishop, Correspondent
• Health Aug 28, 2026 UK Sugar Rationing Study Links Early Childhood Diet to Cancer, Dementia, and Heart Risk Decades Later A wave of studies using postwar Britain's natural experiment shows that sugar restriction in the first 1,000 days of life may shape disease risk well into old age, but researchers warn the data can't prove cause and effect.
  By Karen Bishop, Correspondent
• Health Aug 27, 2026 Cyclospora Outbreak Tied to Lettuce Tops 10,900 Cases Across 17 States A multistate Cyclospora outbreak linked to iceberg lettuce from a Mexican supplier has sent more than 450 people to the hospital and killed two in Michigan, making it one of the largest on U.S. record.
  By Karen Bishop, Correspondent
• Health Aug 25, 2026 Everyday Prescriptions Leave Lasting Mark on Gut Bacteria, Large Estonian Study Finds Antidepressants, beta-blockers, acid reducers, and benzodiazepines reshaped gut microbiome composition for years after patients stopped taking them, according to research published in ASM's journal mSystems.
  By Karen Bishop, Correspondent
• Health Aug 23, 2026 Nurse-Led Protocols Cut Hospital C. diff Infections by 90% on Nephrology Unit A new report finds that giving bedside nurses authority to initiate Clostridioides difficile testing and isolation protocols slashed hospital-acquired infections on one inpatient nephrology unit, adding weight to calls for wider policy adoption.
  By Karen Bishop, Correspondent
• Health Aug 17, 2026 Hospitals Spread 'I Gave Birth' Wristband Program to Cut Postpartum Deaths An initiative launched by a North Carolina health system in 2021 has reached hospitals in at least 26 states, betting a silicone bracelet can keep new mothers alive past their six-week checkup.
  By Karen Bishop, Correspondent
• Health Aug 16, 2026 Trump Order to Split MMR Shot Alarms Pediatricians as Measles Cases Hit 35-Year High President Trump signed an executive order calling for the combined measles-mumps-rubella vaccine to be divided into three separate injections, a move physicians and public health officials say will reduce uptake at precisely the wrong moment.
  By Karen Bishop, Correspondent
• Health Aug 14, 2026 Nearly Half of U.S. Internists Are Foreign-Born, and They Carry a Disproportionate Share of Safety-Net Care A JAMA study of 249,000 board-certified internists finds that doctors born abroad make up 47% of the field and are far more likely to treat low-income, Black, Latino, and disabled patients.
  By Karen Bishop, Correspondent
• Health Aug 13, 2026 Trump Signs Order to Break Up MMR Vaccine Into Three Separate Shots The August 10 executive order rewrites the childhood immunization schedule, but clinicians say the science doesn't support it and manufacturers have little incentive to comply.
  By Karen Bishop, Correspondent
• Health Aug 12, 2026 Trump Signs Order to Split MMR Vaccine Into Three Shots, Defying Medical Consensus The August 10 executive order recommends breaking the combined measles, mumps, and rubella vaccine into separate doses at separate visits, a move pediatricians and infectious disease experts say has no scientific basis.
  By Karen Bishop, Correspondent
• Health Aug 11, 2026 Medicaid Work Rules Take Effect With Millions of Patients at Risk of Coverage Loss A CMS rule that took effect July 31 narrows who qualifies as 'medically frail,' leaving states scrambling to rebuild eligibility systems before a January 2027 deadline that researchers say could strip coverage from millions of eligible adults.
  By Karen Bishop, Correspondent
• Health Aug 9, 2026 Drug-Resistant Candida auris Reaches 26 States, CDC Data Shows More than 3,400 infections have been documented in the U.S. so far this year, with Texas, Michigan, and Illinois carrying the heaviest caseloads, and some strains resistant to every available antifungal.
  By Karen Bishop, Correspondent
• Health Aug 7, 2026 Drug-Resistant Candida auris Reaches 23 States as CDC Logs More Than 3,000 Cases in 2026 CDC surveillance data show the antifungal-resistant yeast has spread to nearly half the country, with cases concentrated in hospital and long-term care patients on invasive devices.
  By Karen Bishop, Correspondent
• Health Aug 5, 2026 Once-Weekly HIV Pill Matches Daily Therapy in Phase 3 Trials Data from two international trials presented at AIDS 2026 show a single weekly tablet combining islatravir and lenacapavir kept HIV suppressed as well as current daily regimens at 48 weeks.
  By Karen Bishop, Correspondent
• Health Aug 3, 2026 Once-Weekly Interval Walking Cuts Belly Fat as Well as Three-Day Routine, Trial Finds A four-month randomized trial out of the University of Hong Kong found that cramming 75 minutes of high-intensity interval walking into a single weekly session produced fat-loss results comparable to spreading the same workout across three days.
  By Karen Bishop, Correspondent
• Health Aug 2, 2026 Phase III Trial Backs Cavity-Arresting Liquid for Young Children, Bolstering FDA Drug Application A University of Michigan-led trial published in JAMA Pediatrics found that silver diamine fluoride stopped decay in more than half of treated baby teeth with no drilling, shots, or sedation.
  By Karen Bishop, Correspondent
• Health Aug 1, 2026 Phase III Trial Finds Painted-On Liquid Stops Cavities in Young Children Without Drilling A University of Michigan-led study published in JAMA Pediatrics found silver diamine fluoride arrested decay in more than half of baby teeth treated, with no drilling, injections, or sedation required.
  By Karen Bishop, Correspondent
• Health Jul 31, 2026 Phase III Trial Shows Silver Diamine Fluoride Stops Cavities in Young Children Without Drilling or Sedation A U.S. trial of 830 children under age 6 found the liquid arrested decay in more than half of treated baby teeth, with no drilling, shots, or anesthesia required.
  By Karen Bishop, Correspondent
• Health Jul 26, 2026 FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol Merck's Lipfendra (enlicitide) becomes the first pill in a drug class that has required an injection since its introduction, cutting LDL by more than half in Phase 3 trials.
  By Karen Bishop, Correspondent
• Health Jul 24, 2026 FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol Merck's Lipfendra (enlicitide) gives patients who can't tolerate injections a once-daily pill option, but it still lacks the long-term cardiovascular outcomes data its injectable predecessors carry.
  By Karen Bishop, Correspondent
• Health Jul 17, 2026 Cyclospora Parasite Sickens Thousands Across 34 States as CDC Flags Surveillance Gaps A rapidly expanding cyclosporiasis outbreak has confirmed more than 1,600 domestically acquired cases since May 1, with a concentrated cluster in the Midwest pointing to lettuce or salad greens as a likely vehicle.
  By Karen Bishop, Correspondent
• Health Jul 16, 2026 Nearly Half of Kidney Failure Patients Never Start Transplant Evaluation, Study Finds A national study of more than 720,000 referred patients shows the biggest barrier to a kidney transplant isn't finding a donor, it's surviving the evaluation process itself.
  By Karen Bishop, Correspondent
• Health Jul 14, 2026 Lifestyle Intervention Cuts Cognitive Decline Risk in Older Adults Across Latin America, Trial Finds A two-year randomized trial published in The Lancet shows culturally adapted programs combining exercise, diet, cognitive training, and social support improved brain health in adults aged 60 to 77 across 11 countries.
  By Karen Bishop, Correspondent
• Health Jul 12, 2026 FDA Clears Casgevy Gene Therapy for Sickle Cell Disease in Children as Young as 2 The CRISPR-based one-time treatment from Vertex Pharmaceuticals now covers toddlers and young children, extending a label that previously started at age 12.
  By Karen Bishop, Correspondent
• Health Jul 8, 2026 U.S. Measles Cases Hit 2,170 With Five Months Left, Threatening Elimination Status CDC data updated July 2 show this year's confirmed case count is just 119 short of the full-year 2025 record, with 93% of infections tied to active outbreaks spanning 41 states and jurisdictions.
  By Karen Bishop, Correspondent
• Health Jul 7, 2026 FDA Clears Casgevy Gene Therapy for Sickle Cell Patients as Young as 2 The CRISPR-based one-time treatment was previously limited to patients 12 and older; the label expansion opens eligibility to an estimated 5,500 additional U.S. children.
  By Karen Bishop, Correspondent
• Health Jul 6, 2026 FDA Clears Casgevy Gene Therapy for Sickle Cell Patients as Young as 2 The CRISPR-based one-time treatment was previously limited to patients 12 and older; the label expansion opens access to an estimated 5,500 additional American children.
  By Karen Bishop, Correspondent
• Health Jul 5, 2026 Half of Kidney Failure Patients Referred for Transplant Never Start the Evaluation Process, Study Finds A national analysis of more than 720,000 patients shows most Americans referred for a kidney transplant drop out before they ever reach the waitlist, with rural location, marital status, and income among the strongest predictors.
  By Karen Bishop, Correspondent
• Health Jul 4, 2026 Medicare Launches $50-a-Month GLP-1 Weight-Loss Coverage for Seniors A new CMS demonstration program opened July 1, giving eligible Medicare Part D enrollees access to Wegovy, Zepbound, and Foundayo for a flat $50 monthly copay, but the fine print matters.
  By Karen Bishop, Correspondent
• Health Jul 3, 2026 U.S. Death Rate Hits Century-Low, but Racial Gaps Persist, CDC Data Show A new CDC provisional report puts the 2025 age-adjusted death rate at 689 per 100,000, the lowest since federal tracking began, while gaps by race and sex remain wide.
  By Karen Bishop, Correspondent
• Health Jul 2, 2026 Medicare Launches $50-a-Month GLP-1 Weight Loss Program for Older Adults A CMS demonstration called the GLP-1 Bridge went live July 1, giving eligible Medicare Part D enrollees access to Wegovy, Zepbound, and Foundayo at a flat $50 monthly copay, but the program has a firm expiration date and notable carve-outs.
  By Karen Bishop, Correspondent
• Health Jul 1, 2026 FDA Scientists Find Little Evidence for Seven Peptides Kennedy Backs for Compounding Agency reviewers say compounds including BPC-157 and TB-500 lack human data, setting up a clash with HHS Secretary RFK Jr. ahead of a July 23 advisory panel vote.
  By Karen Bishop, Correspondent
• Health Jun 28, 2026 Medicaid and ACA Enrollment Falls by More Than 5 Million in a Year A new report finds combined Medicaid and ACA marketplace enrollment dropped by more than 5 million people over the past 12 months, driven by federal spending cuts and the expiration of enhanced insurance subsidies.
  By Karen Bishop, Correspondent

Meet the newsroom

Nine staff reporters, one per desk. Click any name to see their bio, read their pieces, or send the desk a tip.

Marcus Reyes

US desk

Elke Vogel

World desk

Sasha Park

Business desk

Theo Okafor

Technology desk

Renée Kovac

Security desk

Dr. Maya Iyer

Science desk

Karen Bishop

Health desk

Mara Rivera

Entertainment desk

Frank Donovan

Sports desk

Volunteer / internship seats now open — Join the Newswire Apply →